Lv7
4280 积分 2024-03-07 加入
Efficacy and safety of adjuvant TTFields plus pembrolizumab and temozolomide in newly diagnosed glioblastoma: A phase 2 study
6小时前
待确认
Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG12-2)
8小时前
待确认
Real-world outcomes of systemic therapy in locally advanced, recurrent or metastatic cutaneous squamous cell carcinoma
8小时前
已关闭
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
8小时前
待确认
Adjuvant management of locally advanced oral squamous cell carcinoma – real-world challenges and opportunities
8小时前
待确认
Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck
8小时前
待确认
A multi-center, single-arm, phase II study of pemigatinib combined with immune checkpoint inhibitor in FGFR1/2/3 alteration advanced solid tumor
23小时前
待确认
Epidermal growth factor receptor‑targeted antibody nimotuzumab combined with chemoradiotherapy improves survival in patients with locally advanced head and neck squamous cell carcinoma: a propensity score matching real‐world study
5天前
已完结
[Multidisciplinary expert consensus on diagnosis and treatment of eosinophilic granulomatosis with polyangiitis (2025 Edition)]
27天前
已完结
Deep and Durable Prostate-specific Antigen Response to Darolutamide with Androgen Deprivation Therapy and Docetaxel, and Association with Clinical Outcomes for Patients with High- or Low-volume Metastatic Hormone-sensitive Prostate Cancer: Analyses of the Randomized Phase 3 ARASENS Study
1个月前
已完结
皖公网安备34019202002308
